Michael F. Burgess - 01 Jun 2021 Form 4 Insider Report for SpringWorks Therapeutics, Inc. (SWTX)

Role: Head of Research & Development
Signature: /s/ Francis I. Perier, Jr., Attorney-in-fact
Issuer symbol: SWTX
Transactions as of: 01 Jun 2021
Net transactions value: $0
Form type: 4
Filing time: 01 Jun 2021, 17:25:32 UTC
Previous filing: 10 May 2021
Next filing: 14 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SWTX	Common Stock	Award	$0	+27,500		$0.000000	27,500	01 Jun 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SWTX	Stock Option (Right to Buy)	Award	$0	+225,000		$0.000000	225,000	01 Jun 2021	Common Stock	225,000	$81.68	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock awards. The restricted stock awards shall vest as follows: thirty three percent (33%) to vest on June 1, 2022, another thirty three percent (33%) to vest on June 1, 2023 and the remaining thirty four percent (34%) to vest on June 1, 2024, such that the restricted stock awards are fully vested on June 1, 2024, subject to continued service to the Company by the Reporting Person.
F2	This option shall vest as follows: twenty five percent (25%) on June 1, 2022, and thereafter in thirty six (36) equal monthly installments until fully vested, subject to continued service to the Company by the Reporting Person.

Content

Represents restricted stock awards. The restricted stock awards shall vest as follows: thirty three percent (33%) to vest on June 1, 2022, another thirty three percent (33%) to vest on June 1, 2023 and the remaining thirty four percent (34%) to vest on June 1, 2024, such that the restricted stock awards are fully vested on June 1, 2024, subject to continued service to the Company by the Reporting Person.

This option shall vest as follows: twenty five percent (25%) on June 1, 2022, and thereafter in thirty six (36) equal monthly installments until fully vested, subject to continued service to the Company by the Reporting Person.